Audentes Therapeutics is now Astellas Gene Therapies. Read our Press Release and visit www.astellas.com to learn more.

Astellas Pharma Inc.
  • Team
  • Our Approach
  • Innovative Therapies
    • X-Linked Myotubular Myopathy
    • Pompe Disease
    • Myotonic Dystrophy Type 1
  • Careers
  • News
  • Contact
  • Patients + Families
  1. Home
  2. News

News

Jul 26, 2022
Astellas Unveils Plans to Open New Biotech Campus in South San Francisco
Read More
Jun 08, 2022
Astellas Celebrates the Opening of Its New Large-Scale Gene Therapy Manufacturing Facility in North Carolina
Read More
Apr 22, 2022
Notice Regarding Impairment Loss for Products under Development
Read More
Feb 07, 2022
Astellas Announces Positive Safety Data from the FORTIS Study of AT845 in Adults with Late-Onset Pompe Disease
Read More
Dec 02, 2021
Astellas and Dyno Therapeutics Announce Research Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle
Read More
Sep 14, 2021
Astellas Reports Update to Sept. 1 Announcement on the ASPIRO Clinical Trial of AT132 in Patients with X-linked Myotubular Myopathy
Read More
Sep 01, 2021
Astellas Provides Update on ASPIRO Clinical Trial of AT132 in Patients with X-linked Myotubular Myopathy
Read More
Mar 31, 2021
Audentes Therapeutics Expands Mission, Becomes Astellas Gene Therapies
Read More
Dec 24, 2020
Audentes Therapeutics Announces FDA Lifts Hold on ASPIRO Clinical Trial of AT132 for Treatment of X-Linked Myotubular Myopathy (XLMTM)
Read More

Pagination

  • Current page 1
  • Page 2
  • Next page Next ›
  • Last page Last »

Footer Menu 1

  • TEAM
  • OUR APPROACH

Footer Menu 2

  • INNOVATIVE THERAPIES
    • X-Linked Myotubular Myopathy
    • Pompe Disease
    • Myotonic Dystrophy Type 1

Footer Menu 3

  • CAREERS
  • NEWS
  • CONTACT
  • PATIENTS + FAMILIES
  • US PRIVACY POLICY
  • EU PRIVACY POLICY
600 California Street, 17th Floor
San Francisco, CA 94108
Phone: (415) 818-1001
Email: [email protected]
© Copyright 2022 Audentes Therapeutics. Terms and Conditions | Privacy Statement
  • facebook icon
  • linkedin icon
  • twitter icon
back to top